Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.80 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.79 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.77 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.68 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | NAAA | Q02083 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CES2 | O00748 | 2/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18203194 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL7060548 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL8972980 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL9415758 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL768398 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL8972823 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL8972813 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL1044731 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL4450061 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A | |
| SCHEMBL8972566 | 1.00 | L3MBTL1 (0.80) | L3MBTL1GNAI3GNAI1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2269995-B1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DAINIPPON INK & CHEMICALS (JP) | 2012-12-12 | — | — | EP | disclosed |
| US-8017706-B2 | Process for production of polymers with iron complex catalyst | DIC CORPORATION (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporatio (JP) | 2011-05-05 | — | — | US | disclosed |
| EP-2269995-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | DIC Corporation (JP) | 2011-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105703-A1 | PROCESS FOR PRODUCTION OF POLYMERS WITH IRON COMPLEX CATALYST | TFRC, FECH, FTH1 | L3MBTL1 4842/4885GNAI3 3405/4885GNAI1 3846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.